US Stocks
US Options
Emerging Asia
GBP Cash Savings
Charts & Tools
Paper Trading
Extended Hours
Wall Street JournalV
VERU
Veru
0.48
0.03+7.38%After Hours: 0.4842 -0.00 -0.04%19:18 03/14 EDT
OPEN/PREV CLOSE0.4500/0.4511
TODAY RANGE0.4500-0.4899
VOL1.27M
MARKET CAP70.91M
52 WEEK RANGE0.4500-1.920
AVG VOL (3M)3.45M
% TURNOVER0.86%
TURNOVER--
P/E (TTM)-1.8439
% RANGE8.85%
EPS(TTM)-0.2627
P/E(FORWARD)-2.1529
P/B2.663
BVPS0.1819
DIVIDEND--
P/S4.198
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP57.69M
SHARES OUTSTANDING146.38M
NEXT EARNINGS05/06-05/12
FREE FLOAT119.10M
LOT SIZE1
EX-DIV DATE04/28/2014
News
Press Releases
Financial Reports
Profile
Seeking Alpha·6d ago
Viking, other obesity players fall following Novo Nordisk CagriSema results
Seeking Alpha·03/08 18:30
Weight-loss drug battle: Who are the latest players involved
TipRanks·02/21 02:04
Director Makes Bold Move with Major Veru Stock Purchase!
Reuters·02/19 11:00
FOCUS-Next generation weight loss drugs aim to save muscle
Reuters·02/14 13:19
VERU <VERU.O>: OPPENHEIMER CUTS TARGET PRICE TO $4 FROM $5
TipRanks·02/14 03:57
Veru Inc. Reports Strong Q1 Results and Clinical Progress
TipRanks·02/14 00:04
Veru Inc Earnings Call: Clinical Wins Amid Financial Concerns
Seeking Alpha·02/13 19:36
Veru targets Phase 3 enobosarm trials following promising Phase 2b results in obesity treatment
TipRanks·02/13 11:46
Veru reports Q1 cont-op EPS (1c) vs. (8c) last year
Benzinga·02/13 11:38
Veru Q1 Adj EPS $(0.07) Beats $(0.08) Estimate
Reuters·02/13 11:33
VERU INC - Q1 NET LOSS FROM CONT OPS $0.01 PER SHARE
Same Industry
Name/Symbol
Change%
Price